Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Lanzolla

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Lancet. Diabetes & Endocrinology|September 30, 2021
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trialGiulia Lanzolla, Elena Sabini, Marenza Leo, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 15, 2019
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four casesIsabella Lupi, Alessandro Brancatella, Mirco Cosottini, et al.
Journal of Endocrinological Investigation|October 7, 2024
Long-term outcome of Graves' orbitopathy following treatment with sirolimusSimone Comi, Giada Cosentino, Giulia Lanzolla, et al.
JCI Insight|August 1, 2024
HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylationMohd P Khan, Elena Sabini, Katherine Beigel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2024
Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiencyGiulia Lanzolla, Elena Sabini, Katherine Beigel, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 19, 2026
Light Discomfort Thresholds in Patients with Moderate-to-Severe Active versus Mild Non-Active Thyroid Eye DiseaseFilippo Lixi, Silvia Corrias, Giulia Coco, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2021
Genetic Profiling of Orbital Fibroblasts from Patients with Graves' OrbitopathyGiovanna Rotondo Dottore, Ilaria Bucci, Giulia Lanzolla, et al.
European Journal of Endocrinology|April 16, 2026
Early Familial Non-Medullary Thyroid Cancer: Differences with Late-Onset and Sporadic FormsChiara Mura, Silvia Corrias, Mara Lecca, et al.
Thyroid : Official Journal of the American Thyroid Association|February 5, 2025
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort StudyGiada Cosentino, Giulia Lanzolla, Simone Comi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2026
Subclinical Ocular Alterations in Graves' Disease: The FUMO Score, a New Tool to Predict Graves' Orbitopathy ProgressionGiulia Lanzolla, Francesca Saba, Silvia Corrias, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Lancet. Diabetes & Endocrinology|September 30, 2021
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trialGiulia Lanzolla, Elena Sabini, Marenza Leo, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 15, 2019
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four casesIsabella Lupi, Alessandro Brancatella, Mirco Cosottini, et al.
Journal of Endocrinological Investigation|October 7, 2024
Long-term outcome of Graves' orbitopathy following treatment with sirolimusSimone Comi, Giada Cosentino, Giulia Lanzolla, et al.
JCI Insight|August 1, 2024
HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylationMohd P Khan, Elena Sabini, Katherine Beigel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2024
Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiencyGiulia Lanzolla, Elena Sabini, Katherine Beigel, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 19, 2026
Light Discomfort Thresholds in Patients with Moderate-to-Severe Active versus Mild Non-Active Thyroid Eye DiseaseFilippo Lixi, Silvia Corrias, Giulia Coco, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2021
Genetic Profiling of Orbital Fibroblasts from Patients with Graves' OrbitopathyGiovanna Rotondo Dottore, Ilaria Bucci, Giulia Lanzolla, et al.
European Journal of Endocrinology|April 16, 2026
Early Familial Non-Medullary Thyroid Cancer: Differences with Late-Onset and Sporadic FormsChiara Mura, Silvia Corrias, Mara Lecca, et al.
Thyroid : Official Journal of the American Thyroid Association|February 5, 2025
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort StudyGiada Cosentino, Giulia Lanzolla, Simone Comi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2026
Subclinical Ocular Alterations in Graves' Disease: The FUMO Score, a New Tool to Predict Graves' Orbitopathy ProgressionGiulia Lanzolla, Francesca Saba, Silvia Corrias, et al.
Pageof 4